Axordia Overview
- Founded
- 2001
- Status
- Acquired/Merged
- Latest Deal Type
- M&A
Axordia General Information
Description
Operator of a human embryonic stem cell company. The company develops drugs using the properties of stem cells and their derivatives as part of the drug discovery process.
Contact Information
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
- The Sheffield Bioincubator
- 40 Leavygreave Road
- Sheffield S3 7RD
- England, United Kingdom
+44 0114 000 0000
Axordia Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 00.000 | Completed | Product Development | |||
| 3. Early Stage VC | 01-Jan-2006 | 00000 | 00.000 | Completed | Startup | |
| 2. Grant | 01-Apr-2002 | $362K | Completed | |||
| 1. Early Stage VC | 12-Nov-2001 | $362K | $362K | Completed | Product Development |
Axordia Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| V Gerskowitch | Chief Executive Officer |
Axordia Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| FusionIP | Venture Capital | Minority | 000 0000 | 000000 0 | |
| White Rose Technology Seedcorn Fund | Venture Capital | Minority | 000 0000 | 000000 0 |